7975 Share Price | LIHIT LAB., INC. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare LIHIT LAB., INC. with Similar Stocks

Imura & Co. Ltd.Yagami Inc.Takano Co., Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 1.99%

The company has been able to generate a Return on Equity (avg) of 1.99% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of -1.24% and Operating profit at -18.37% over the last 5 years

With a fall in Net Sales of -7.88%, the company declared Very Negative results in May 25

With ROE of 3.85%, it has a very attractive valuation with a 0.41 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

JPY 4,972 Million (Micro Cap)

P/E

11.00

Industry P/E

Dividend Yield

0.12%

Debt Equity

-0.09

Return on Equity

1.73%

Price to Book

0.46

Revenue and Profits:

Net Sales:

1,910 Million

(Quarterly Results - Nov 2025)

Net Profit:

-5 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

14.52%

6 Months

15.66%

1 Year

9.42%

2 Years

40.44%

3 Years

48.95%

4 Years

42.79%

5 Years

59.75%

LIHIT LAB., INC. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

LIHIT LAB., INC. Sees Valuation Upgrade Amid Operational Challenges and Declining Sales

LIHIT LAB., INC. has recently experienced a change in its valuation grade, reflecting shifts in its financial metrics. Key indicators include a P/E ratio of 11 and a price-to-book value of 0.41. However, challenges persist, including a low return on equity and declining net sales over the past five years.

Read full news article

LIHIT LAB., INC. Adjusts Valuation Amidst Growth Challenges and Competitive Metrics

LIHIT LAB., INC. has recently experienced a change in its evaluation, reflecting a more favorable assessment of its valuation metrics. Key indicators include a P/E ratio of 11 and a low EV to Sales ratio of 0.27, although the company faces growth challenges with declining net sales and low return on equity.

Read full news article

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-1.24%

EBIT Growth (5y)

-18.37%

EBIT to Interest (avg)

0.66

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.18

Sales to Capital Employed (avg)

0.83

Tax Ratio

19.70%

Dividend Payout Ratio

20.61%

Pledged Shares

Institutional Holding

ROCE (avg)

1.97%

ROE (avg)

1.99%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.41

EV to EBIT

14.01

EV to EBITDA

5.37

EV to Capital Employed

0.29

EV to Sales

0.27

PEG Ratio

0.02

Dividend Yield

0.13%

ROCE (Latest)

2.04%

ROE (Latest)

3.85%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Nov'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Nov 2025 is -7.88% vs 0.71% in Nov 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Nov 2025 is -102.77% vs 392.51% in Nov 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,910.40",
          "val2": "2,073.80",
          "chgp": "-7.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.80",
          "val2": "74.20",
          "chgp": "-58.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "1.30",
          "chgp": "-30.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.30",
          "val2": "1.70",
          "chgp": "-23.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.20",
          "val2": "187.50",
          "chgp": "-102.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-20.60%",
          "val2": "0.10%",
          "chgp": "-2.07%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2025 is 4.74% vs 3.40% in Feb 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2025 is 539.27% vs -284.02% in Feb 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,220.50",
          "val2": "8,803.50",
          "chgp": "4.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "466.10",
          "val2": "9.90",
          "chgp": "4,608.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.00",
          "val2": "4.70",
          "chgp": "27.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.00",
          "val2": "4.40",
          "chgp": "-31.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "411.60",
          "val2": "-93.70",
          "chgp": "539.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.30%",
          "val2": "-31.70%",
          "chgp": "5.10%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Nov'25 - YoY

Nov'25

Nov'24

Change(%)

Net Sales

1,910.40

2,073.80

-7.88%

Operating Profit (PBDIT) excl Other Income

30.80

74.20

-58.49%

Interest

0.90

1.30

-30.77%

Exceptional Items

1.30

1.70

-23.53%

Consolidate Net Profit

-5.20

187.50

-102.77%

Operating Profit Margin (Excl OI)

-20.60%

0.10%

-2.07%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Nov 2025 is -7.88% vs 0.71% in Nov 2024

Consolidated Net Profit

YoY Growth in quarter ended Nov 2025 is -102.77% vs 392.51% in Nov 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Feb'25

Feb'25

Feb'24

Change(%)

Net Sales

9,220.50

8,803.50

4.74%

Operating Profit (PBDIT) excl Other Income

466.10

9.90

4,608.08%

Interest

6.00

4.70

27.66%

Exceptional Items

3.00

4.40

-31.82%

Consolidate Net Profit

411.60

-93.70

539.27%

Operating Profit Margin (Excl OI)

19.30%

-31.70%

5.10%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Feb 2025 is 4.74% vs 3.40% in Feb 2024

Consolidated Net Profit

YoY Growth in year ended Feb 2025 is 539.27% vs -284.02% in Feb 2024

All Annual Results

Company CV

About LIHIT LAB., INC.

LIHIT LAB., INC.

Miscellaneous

No Details Available.

Company Coordinates

No Company Details Available